Catapharma Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-06-2024
- Paid Up Capital ₹ 5.00 M
as on 16-06-2024
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.82 Cr
as on 16-06-2024
- Satisfied Charges ₹ 17.96 Cr
as on 16-06-2024
- Revenue 31.49%
(FY 2023)
- Profit 35.17%
(FY 2023)
- Ebitda 34.22%
(FY 2023)
- Net Worth 29.33%
(FY 2023)
- Total Assets 29.56%
(FY 2023)
About Catapharma Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹6.82 Cr. The company has closed loans amounting to ₹17.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shruti Karwa, Pravin Marawar, and Shrikant Karwa serve as directors at the Company.
- CIN/LLPIN
U24110MH1989PTC051439
- Company No.
051439
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Catapharma Chemicals Private Limited offer?
Catapharma Chemicals Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Amine Compounds, Organic Chemicals, Cyclohexylamine, API (Active Pharmaceutical Ingredients), Veterinary Medicines, Anthelmintics, Organic Compounds, Piperidine, Flavours & Aromatics.
Who are the key members and board of directors at Catapharma Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shrikant Karwa  | Managing Director | 20-Apr-1989 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shruti Karwa | Director | 18-Feb-2021 | Current |
| Pravin Marawar | Director | 20-Apr-1989 | Current |
Financial Performance of Catapharma Chemicals.
Catapharma Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.49% increase. The company also saw a substantial improvement in profitability, with a 35.17% increase in profit. The company's net worth Soared by an impressive increase of 29.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Catapharma Chemicals?
In 2023, Catapharma Chemicals had a promoter holding of 37.60% and a public holding of 62.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Catapro Pharmalab Private LimitedActive 1 year 7 monthsShruti Karwa and Shrikant Karwa are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Nov 2019 | ₹4.13 Cr | Open |
Dbs Bank Ltd Creation Date: 08 Mar 2017 | ₹2.00 Cr | Open |
The State Industrial & Investment Co. Of Maharashtra Limited Creation Date: 21 Feb 1990 | ₹6.90 M | Open |
How Many Employees Work at Catapharma Chemicals?
Catapharma Chemicals has a workforce of 56 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Catapharma Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Catapharma Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
